Recent investments in new PCI programs in the US have been systematically duplicative, increasing costs without significantly improving patient access to timely reperfusion.
No takes yet. Share an insight, caveat, or question.
Minimal access gains despite PCI expansion warrant caution on further duplication; leaves open optimal regional planning strategies.
Concannon et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: